BR112012025391A2 - esponja, uso de uma esponja, método de tratamento de uma lesão, kit, método de fabricação de uma esponja hemostática, e , compósito hemostático - Google Patents
esponja, uso de uma esponja, método de tratamento de uma lesão, kit, método de fabricação de uma esponja hemostática, e , compósito hemostáticoInfo
- Publication number
- BR112012025391A2 BR112012025391A2 BR112012025391A BR112012025391A BR112012025391A2 BR 112012025391 A2 BR112012025391 A2 BR 112012025391A2 BR 112012025391 A BR112012025391 A BR 112012025391A BR 112012025391 A BR112012025391 A BR 112012025391A BR 112012025391 A2 BR112012025391 A2 BR 112012025391A2
- Authority
- BR
- Brazil
- Prior art keywords
- sponge
- hemostatic
- injury
- kit
- treating
- Prior art date
Links
- 230000002439 hemostatic effect Effects 0.000 title abstract 5
- 239000002131 composite material Substances 0.000 title abstract 3
- 208000027418 Wounds and injury Diseases 0.000 title abstract 2
- 230000006378 damage Effects 0.000 title abstract 2
- 208000014674 injury Diseases 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 abstract 3
- 239000012620 biological material Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
- A61L24/0094—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00106—Wound bandages emergency bandages, e.g. for first aid
- A61F2013/0011—Wound bandages emergency bandages, e.g. for first aid spray
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Composite Materials (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Abstract
esponja, uso de uma esponja, método de tratamento de uma lesão, kit, método de fabricação de uma esponja hemostática, e , compósito hemostático. a presente invenção provê uma esponja compósita porosa hemostática compreendendo i) uma matriz de um biomaterail e ii) um componente polimérico hidrofilico compreendendo grupos reativos em que i) e ii) são associados uns aos outros, de modo que a reatividade do componente polimérico é retida, em que associado significa que - referido componente polimérico é revestido sobre uma superfície da referida matriz de um biomaterial, ou - a referida matriz está impregnada com o referido material polimérico, ou - ambos.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32166110P | 2010-04-07 | 2010-04-07 | |
US61/321661 | 2010-04-07 | ||
US42403110P | 2010-12-16 | 2010-12-16 | |
US61/424031 | 2010-12-16 | ||
PCT/EP2011/055418 WO2011124640A1 (en) | 2010-04-07 | 2011-04-07 | Hemostatic sponge |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112012025391A2 true BR112012025391A2 (pt) | 2015-09-22 |
BR112012025391B1 BR112012025391B1 (pt) | 2019-05-14 |
Family
ID=43992901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012025391-3A BR112012025391B1 (pt) | 2010-04-07 | 2011-04-07 | Esponja compósita porosa hemostática, kit, método de fabricação de uma esponja hemostática, e, compósito hemostático |
Country Status (27)
Country | Link |
---|---|
US (6) | US8703170B2 (pt) |
EP (4) | EP2555804B1 (pt) |
JP (1) | JP5856142B2 (pt) |
KR (1) | KR101832518B1 (pt) |
CN (1) | CN102939113B (pt) |
AR (1) | AR087327A1 (pt) |
AU (1) | AU2011237901B2 (pt) |
BR (1) | BR112012025391B1 (pt) |
CA (1) | CA2795099C (pt) |
CL (1) | CL2012002804A1 (pt) |
CO (1) | CO6630171A2 (pt) |
CR (1) | CR20120492A (pt) |
DK (1) | DK2555804T3 (pt) |
ES (3) | ES2971671T3 (pt) |
HK (1) | HK1179904A1 (pt) |
HR (1) | HRP20150896T1 (pt) |
MX (1) | MX2012011635A (pt) |
NZ (1) | NZ602630A (pt) |
PE (1) | PE20130695A1 (pt) |
PL (1) | PL2555804T3 (pt) |
PT (1) | PT2555804E (pt) |
RU (1) | RU2562569C2 (pt) |
SA (1) | SA111320355B1 (pt) |
TW (1) | TWI511753B (pt) |
UY (1) | UY33320A (pt) |
WO (1) | WO2011124640A1 (pt) |
ZA (1) | ZA201207502B (pt) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8932560B2 (en) | 2007-09-04 | 2015-01-13 | University of Maryland, College Parke | Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells |
JP5719355B2 (ja) | 2009-06-16 | 2015-05-20 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | 止血スポンジ |
US8668899B2 (en) | 2009-11-13 | 2014-03-11 | University Of Maryland, College Park | Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds |
KR101811070B1 (ko) | 2009-12-16 | 2017-12-20 | 백스터 인터내셔널 인코포레이티드 | 지혈 스폰지 |
SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
AU2012202543B9 (en) * | 2011-01-04 | 2017-11-02 | Gatt Technologies B.V. | Cross-linked polymers and implants derived from electrophilically activated polyoxazoline |
GB201206190D0 (en) * | 2012-04-05 | 2012-05-23 | Health Prot Agency | Decontaminant product and method |
WO2014160136A1 (en) | 2013-03-13 | 2014-10-02 | University Of Maryland, Office Of Technology Commercialization | Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells |
US10384156B2 (en) | 2014-09-12 | 2019-08-20 | Hollingsworth & Vose Company | Filter media comprising fibers including charged particles |
RU2704259C2 (ru) * | 2014-10-06 | 2019-10-25 | Гатт Текнолоджиз Б. В. | Пористый гемостатический продукт со свойством адгезии к тканям |
GB2533600A (en) * | 2014-12-23 | 2016-06-29 | Nokia Technologies Oy | Music Playing Service |
US10751444B2 (en) | 2015-08-07 | 2020-08-25 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
US10660945B2 (en) | 2015-08-07 | 2020-05-26 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
MX2018005784A (es) * | 2015-11-08 | 2018-11-29 | Omrix Biopharmaceuticals Ltd | Mezcla hemostatica de fibras cortas y largas basadas en celulosa. |
EP3248578A1 (en) * | 2016-05-24 | 2017-11-29 | Biocer-Entwicklungs-GmbH | Unit for hemostasis and arrangement containing the same |
RU2635465C1 (ru) * | 2016-08-10 | 2017-11-13 | Александр Евгеньевич Федотов | Гемостатический материал, гемостатическое средство и перевязочный материал на его основе |
CN106267328B (zh) * | 2016-09-20 | 2019-04-12 | 安徽思维特生物科技有限公司 | 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法 |
CN109906091B (zh) * | 2016-11-07 | 2021-10-15 | 郡是株式会社 | 生物组织增强材料 |
CN109937055A (zh) * | 2016-11-07 | 2019-06-25 | 郡是株式会社 | 生物组织增强材料和人工硬脑膜 |
CN107050502B (zh) * | 2016-12-20 | 2018-11-27 | 欣乐加生物科技有限公司 | 一种超吸水性高分子水凝胶干胶海绵及其制备方法和用途 |
US20210128778A1 (en) | 2017-03-09 | 2021-05-06 | Baxter International Inc. | Solvent deposition system and methods |
RU2652444C1 (ru) * | 2017-04-07 | 2018-04-26 | федеральное государственное бюджетное образовательное учреждение высшего образования "Вологодская государственная молочнохозяйственная академия имени Н.В. Верещагина" (ФГБОУ ВО Вологодская ГМХА) | Способ применения слизи кожи рыб для активации агрегации тромбоцитов и свертывания крови in vitro |
RU179063U1 (ru) * | 2017-07-03 | 2018-04-25 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Салфетка с фибрином |
WO2019071587A1 (en) * | 2017-10-13 | 2019-04-18 | Gunze Limited | BIOLOGICAL TISSUE REINFORCING MATERIAL KIT AND BIOLOGICAL TISSUE REINFORCING MATERIAL |
KR20200093600A (ko) * | 2017-11-28 | 2020-08-05 | 백스터 인터내셔널 인코포레이티드 | 상처-치료용 흡수제 |
US20190192724A1 (en) * | 2017-12-12 | 2019-06-27 | Bio Med Sciences, Inc. | Debriding wound dressing, process of manufacture and useful articles thereof |
JP7296965B2 (ja) | 2017-12-20 | 2023-06-23 | ストライカー・ユーロピアン・ホールディングス・I,リミテッド・ライアビリティ・カンパニー | 生医学用発泡体 |
CN108478849B (zh) * | 2018-02-07 | 2021-04-16 | 广州迈普再生医学科技股份有限公司 | 一种可吸收可黏附止血海绵及其制备方法 |
RU2681184C1 (ru) * | 2018-02-26 | 2019-03-04 | Общество с ограниченной ответственностью "Специальная и медицинская техника" (ООО "Спецмедтехника") | Гемостатическая губка |
CN108742750B (zh) * | 2018-06-21 | 2020-09-22 | 广州迈普再生医学科技股份有限公司 | 组织封堵材料及其制备方法和封堵制品 |
CN109106974B (zh) * | 2018-06-21 | 2021-05-18 | 广州迈普再生医学科技股份有限公司 | 凝胶组织封堵材料及其制备方法和封堵制品 |
CN108815560B (zh) * | 2018-06-21 | 2021-03-12 | 广州迈普再生医学科技股份有限公司 | 多孔组织封堵材料及其制备方法和封堵制品 |
CN108785732B (zh) * | 2018-06-21 | 2021-04-09 | 广州迈普再生医学科技股份有限公司 | 止血封堵材料及其制备方法和止血封堵制品 |
WO2020069376A1 (en) * | 2018-09-27 | 2020-04-02 | Watershed Medical, Inc. | Device and method for treating infections |
MX2021005161A (es) * | 2018-11-02 | 2021-10-13 | Covalon Tech Inc | Composiciones de espuma, matrices de espuma y metodos. |
US11230654B2 (en) * | 2019-06-04 | 2022-01-25 | Halliburton Energy Services, Inc. | Calcium carbonate coated materials and methods of making and using same |
CN114096285A (zh) | 2019-07-12 | 2022-02-25 | 加特技术公司 | 生物相容性柔性止血片 |
ES2950186T3 (es) | 2019-07-12 | 2023-10-05 | Gatt Tech B V | Lámina hemostática, flexible y biocompatible |
JP2022539456A (ja) | 2019-07-12 | 2022-09-09 | ガット テクノロジーズ ビー.ブイ. | 組織接着性シートを調製するための方法 |
WO2021067857A1 (en) | 2019-10-02 | 2021-04-08 | Watershed Medical, Inc. | Device and method for improving retention of a therapy in the bladder |
KR20210052983A (ko) * | 2019-11-01 | 2021-05-11 | 인제대학교 산학협력단 | 의료용 음압 시스템 및 음압적용장치 |
CN111187347B (zh) * | 2020-01-17 | 2023-03-24 | 陕西慧康生物科技有限责任公司 | 重组胶原蛋白、重组胶原海绵材料及其制备方法和应用 |
KR102164819B1 (ko) * | 2020-03-02 | 2020-10-13 | 주식회사 이노테라피 | 지혈용 기구 및 이의 제조방법 |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
US20220062492A1 (en) * | 2020-08-31 | 2022-03-03 | Ethicon, Inc. | Sealant Dressing with Protected Reactive Components |
WO2022169911A1 (en) * | 2021-02-03 | 2022-08-11 | Datascope Corp. | Laminated collagen material and process for producing same |
AU2022220274A1 (en) * | 2021-02-10 | 2023-09-28 | Ethicon, Inc. | Two component sealing systems including synthetic matrices and biosynthetic adhesives |
CN113209357B (zh) * | 2021-05-14 | 2023-02-17 | 南方科技大学 | 复合止血粉 |
CN113855845B (zh) * | 2021-09-28 | 2022-11-01 | 四川大学 | 表面亲水的改性壳聚糖多孔凝胶止血纱布及其制备方法 |
USD1014764S1 (en) * | 2021-11-16 | 2024-02-13 | Raymond Lovell Francis | Skin-attachable block set that provides no-touch protection for skin insults |
CA3240664A1 (en) | 2021-12-17 | 2023-06-22 | Marco WOGRAM | Composition comprising a biomaterial-based porous material coated with a powder |
KR20230164270A (ko) | 2022-05-24 | 2023-12-04 | 단국대학교 천안캠퍼스 산학협력단 | 필름 형태의 지혈제 및 이의 제조방법 |
CN115300665A (zh) * | 2022-08-08 | 2022-11-08 | 北京化工大学 | 一种抗菌可吸收鼻腔止血海绵及其制备方法和应用 |
Family Cites Families (191)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2507244A (en) | 1947-04-14 | 1950-05-09 | Upjohn Co | Surgical gelatin dusting powder and process for preparing same |
CH264752A (de) | 1947-06-03 | 1949-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von Trägern für Arzneimittel. |
US3089815A (en) | 1951-10-11 | 1963-05-14 | Lieb Hans | Injectable pharmaceutical preparation, and a method of making same |
SE420565B (sv) | 1974-06-06 | 1981-10-19 | Pharmacia Ab | Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel |
US4013078A (en) | 1974-11-25 | 1977-03-22 | Feild James Rodney | Intervertebral protector means |
JPS5823410B2 (ja) | 1974-11-12 | 1983-05-14 | 株式会社クラレ | ヒドロゲルヨウキザイ |
JPS51125156U (pt) | 1975-03-31 | 1976-10-09 | ||
US4006220A (en) | 1975-06-04 | 1977-02-01 | Gottlieb Sheldon K | Compositions and methods useful for repairing depressed cutaneous scars |
US4164559A (en) | 1977-09-21 | 1979-08-14 | Cornell Research Foundation, Inc. | Collagen drug delivery device |
DE2843963A1 (de) | 1978-10-09 | 1980-04-24 | Merck Patent Gmbh | Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin |
US4265233A (en) | 1978-04-12 | 1981-05-05 | Unitika Ltd. | Material for wound healing |
US4179400A (en) | 1978-05-09 | 1979-12-18 | W. R. Grace & Co. | Process for preparing catalytic solutions of sulfonium salts |
AT359652B (de) | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
AT359653B (de) | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
DE3036033A1 (de) | 1980-09-24 | 1982-05-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung |
US4300494A (en) | 1979-09-26 | 1981-11-17 | Shell Oil Company | Thermal insulated intake ports |
US4292972A (en) | 1980-07-09 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Lyophilized hydrocolloio foam |
DE3105624A1 (de) | 1981-02-16 | 1982-09-02 | Hormon-Chemie München GmbH, 8000 München | Material zum abdichten und heilen von wunden |
US4424208A (en) | 1982-01-11 | 1984-01-03 | Collagen Corporation | Collagen implant material and method for augmenting soft tissue |
EP0086627B1 (en) | 1982-02-12 | 1985-08-28 | Unitika Ltd. | Anti-cancer device |
US4482386A (en) | 1982-03-26 | 1984-11-13 | Warner-Lambert Company | Method of conditioning a water swellable hydrocolloid |
US4543332A (en) | 1982-03-29 | 1985-09-24 | Miles Laboratories, Inc. | Method for the preparation of spherical microorganism cell aggregates |
US4540410A (en) | 1982-11-16 | 1985-09-10 | Serono Pharmaceutical Partners | Lyophilized compositions, preparation and use thereof |
JPS59113889A (ja) | 1982-12-17 | 1984-06-30 | Sumitomo Chem Co Ltd | 固定化酵素もしくは固定化微生物菌体の製造方法 |
JPS59113889U (ja) | 1983-01-24 | 1984-08-01 | 西部電機工業株式会社 | カウンタ式エンコ−ダ |
JPS605509A (ja) | 1983-06-24 | 1985-01-12 | Hitachi Ltd | 分子線エピタキシ装置 |
EP0132983B2 (en) | 1983-07-14 | 1991-06-12 | Hitachi Chemical Co., Ltd. | Production of gelatin spherical gels and their use |
JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
US4515637A (en) | 1983-11-16 | 1985-05-07 | Seton Company | Collagen-thrombin compositions |
AT389815B (de) | 1984-03-09 | 1990-02-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
US4600574A (en) | 1984-03-21 | 1986-07-15 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Method of producing a tissue adhesive |
US4837285A (en) | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
SE456346B (sv) | 1984-07-23 | 1988-09-26 | Pharmacia Ab | Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning |
JPS6144825A (ja) | 1984-08-09 | 1986-03-04 | Unitika Ltd | 止血剤 |
GB8422950D0 (en) | 1984-09-11 | 1984-10-17 | Warne K J | Hydrogel |
JPS61122222A (ja) | 1984-11-19 | 1986-06-10 | Koken:Kk | コラ−ゲン又はゼラチンとプロタミンとよりなる止血剤 |
US5178883A (en) | 1984-11-29 | 1993-01-12 | Regents Of The University Of Minnesota | Method for promoting hair growth |
US5165938A (en) | 1984-11-29 | 1992-11-24 | Regents Of The University Of Minnesota | Wound healing agents derived from platelets |
US4600533A (en) | 1984-12-24 | 1986-07-15 | Collagen Corporation | Collagen membranes for medical use |
US5007916A (en) | 1985-08-22 | 1991-04-16 | Johnson & Johnson Medical, Inc. | Method and material for prevention of surgical adhesions |
IE59361B1 (en) | 1986-01-24 | 1994-02-09 | Akzo Nv | Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
IL78826A (en) | 1986-05-19 | 1991-05-12 | Yissum Res Dev Co | Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom |
US5300494A (en) | 1986-06-06 | 1994-04-05 | Union Carbide Chemicals & Plastics Technology Corporation | Delivery systems for quaternary and related compounds |
US4946870A (en) | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
US4832686A (en) | 1986-06-24 | 1989-05-23 | Anderson Mark E | Method for administering interleukin-2 |
US4803075A (en) | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
FR2601371B1 (fr) * | 1986-07-11 | 1989-05-12 | Merieux Inst | Procede de traitement du collagene en vue, notamment, d'en faciliter la reticulation et collagene obtenu par application dudit procede |
CA1305069C (en) | 1987-03-11 | 1992-07-14 | John Cornell | Wound dressings in sheet or gelled paste form |
US4885161A (en) | 1987-03-11 | 1989-12-05 | Medi-Tech International Corporation | Wound dressings in gelled paste form |
US5080893A (en) | 1988-05-31 | 1992-01-14 | University Of Florida | Method for preventing surgical adhesions using a dilute solution of polymer |
US5017229A (en) | 1990-06-25 | 1991-05-21 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
US5140016A (en) | 1988-05-31 | 1992-08-18 | University Of Florida | Method and composition for preventing surgical adhesions using a dilute solution of polymer |
US5350573A (en) | 1988-05-31 | 1994-09-27 | University Of Florida Research Foundation, Inc. | Method and composition for preventing surgical adhesions |
US5447966A (en) | 1988-07-19 | 1995-09-05 | United States Surgical Corporation | Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin |
US5041292A (en) | 1988-08-31 | 1991-08-20 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
US4925677A (en) | 1988-08-31 | 1990-05-15 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
US5135751A (en) | 1988-11-16 | 1992-08-04 | Mediventures Incorporated | Composition for reducing postsurgical adhesions |
US5126141A (en) | 1988-11-16 | 1992-06-30 | Mediventures Incorporated | Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5614587A (en) | 1988-11-21 | 1997-03-25 | Collagen Corporation | Collagen-based bioadhesive compositions |
US5510418A (en) | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US4891359A (en) | 1988-12-08 | 1990-01-02 | Johnson & Johnson Patient Care, Inc. | Hemostatic collagen paste composition |
DE3903672C1 (pt) | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
DK223389D0 (da) * | 1989-05-05 | 1989-05-05 | Ferrosan As | Saarsvamp |
EP0493387B1 (en) | 1989-08-10 | 1993-10-20 | W.L. Gore & Associates, Inc. | A medical dispensing system for tissue adhesive components |
US5196185A (en) | 1989-09-11 | 1993-03-23 | Micro-Collagen Pharmaceutics, Ltd. | Collagen-based wound dressing and method for applying same |
FR2652573B1 (fr) | 1989-10-03 | 1991-12-13 | Atochem | Procede de fabrication du 1,1,1-chlorodifluoroethane. |
US5061274A (en) | 1989-12-04 | 1991-10-29 | Kensey Nash Corporation | Plug device for sealing openings and method of use |
US5219328A (en) | 1990-01-03 | 1993-06-15 | Cryolife, Inc. | Fibrin sealant delivery method |
US5134229A (en) | 1990-01-12 | 1992-07-28 | Johnson & Johnson Medical, Inc. | Process for preparing a neutralized oxidized cellulose product and its method of use |
JPH0813750B2 (ja) | 1990-03-01 | 1996-02-14 | 持田製薬株式会社 | 経口用トロンビン製剤 |
US5306501A (en) | 1990-05-01 | 1994-04-26 | Mediventures, Inc. | Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers |
US5595735A (en) | 1990-05-23 | 1997-01-21 | Johnson & Johnson Medical, Inc. | Hemostatic thrombin paste composition |
US5634943A (en) | 1990-07-12 | 1997-06-03 | University Of Miami | Injectable polyethylene oxide gel implant and method for production |
US5209776A (en) | 1990-07-27 | 1993-05-11 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
US5292362A (en) | 1990-07-27 | 1994-03-08 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
US5108421A (en) | 1990-10-01 | 1992-04-28 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5192300A (en) | 1990-10-01 | 1993-03-09 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
NZ240214A (en) | 1990-10-16 | 1993-02-25 | Takeda Chemical Industries Ltd | Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs |
US5129882A (en) | 1990-12-27 | 1992-07-14 | Novoste Corporation | Wound clotting device and method of using same |
US5690675A (en) | 1991-02-13 | 1997-11-25 | Fusion Medical Technologies, Inc. | Methods for sealing of staples and other fasteners in tissue |
US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
AU654574B2 (en) | 1991-06-14 | 1994-11-10 | Amgen, Inc. | Collagen film drug delivery for proteins |
NL9101051A (nl) | 1991-06-18 | 1993-01-18 | Ashridge Ag | Sluitinrichting voor een bloedvat of dergelijke. |
AT398079B (de) | 1991-11-04 | 1994-09-26 | Immuno Ag | Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung |
JP3267972B2 (ja) | 1992-02-28 | 2002-03-25 | コラーゲン コーポレイション | 高濃度均質化コラーゲン組成物 |
US5204382A (en) | 1992-02-28 | 1993-04-20 | Collagen Corporation | Injectable ceramic compositions and methods for their preparation and use |
US5468505A (en) | 1992-02-28 | 1995-11-21 | Board Of Regents, The University Of Texas System | Local delivery of fibrinolysis enhancing agents |
AU666712B2 (en) | 1992-02-28 | 1996-02-22 | Cohesion Technologies, Inc. | Injectable ceramic compositions and methods for their preparation and use |
US5384333A (en) | 1992-03-17 | 1995-01-24 | University Of Miami | Biodegradable injectable drug delivery polymer |
WO1993021844A1 (en) | 1992-04-23 | 1993-11-11 | Scimed Life Systems, Inc. | Apparatus and method for sealing vascular punctures |
IL105529A0 (en) | 1992-05-01 | 1993-08-18 | Amgen Inc | Collagen-containing sponges as drug delivery for proteins |
JPH05308969A (ja) | 1992-05-13 | 1993-11-22 | Japan Vilene Co Ltd | 酵素保持体及びその製造方法 |
AU4406793A (en) | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
US5385606A (en) | 1992-07-06 | 1995-01-31 | Kowanko; Nicholas | Adhesive composition and method |
US5413571A (en) | 1992-07-16 | 1995-05-09 | Sherwood Medical Company | Device for sealing hemostatic incisions |
US5428022A (en) | 1992-07-29 | 1995-06-27 | Collagen Corporation | Composition of low type III content human placental collagen |
US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
DE4227681C2 (de) | 1992-08-21 | 1995-05-18 | Becker & Co Naturinwerk | Wundabdeckungsmaterial auf der Basis von Kollagenfasern und Verfahren zu seiner Herstellung |
CA2149221C (en) | 1992-11-12 | 2005-02-08 | Neville Alleyne | Cardiac protection device |
JPH0824325B2 (ja) | 1993-01-25 | 1996-03-06 | 日本電気株式会社 | 携帯電話機 |
US5667839A (en) | 1993-01-28 | 1997-09-16 | Collagen Corporation | Human recombinant collagen in the milk of transgenic animals |
JPH08131B2 (ja) | 1993-03-05 | 1996-01-10 | 新田ゼラチン株式会社 | 止血用パッド |
DE69427908T2 (de) | 1993-05-31 | 2001-11-22 | Kaken Pharma Co Ltd | Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält |
JPH0790241A (ja) | 1993-09-22 | 1995-04-04 | Menicon Co Ltd | 眼用レンズ材料用仮接着剤 |
ES2227542T3 (es) | 1993-11-03 | 2005-04-01 | Clarion Pharmaceuticals, Inc. | Parche hemostatico. |
FR2715309B1 (fr) | 1994-01-24 | 1996-08-02 | Imedex | Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé. |
US5674275A (en) | 1994-04-06 | 1997-10-07 | Graphic Controls Corporation | Polyacrylate and polymethacrylate ester based hydrogel adhesives |
US5531759A (en) | 1994-04-29 | 1996-07-02 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
JP3107726B2 (ja) | 1994-05-13 | 2000-11-13 | 株式会社クラレ | 水膨潤性高分子ゲル |
US5658592A (en) | 1994-05-13 | 1997-08-19 | Kuraray Co., Ltd. | Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane |
GB9415739D0 (en) | 1994-07-30 | 1994-09-21 | Scimat Ltd | Gel wound dressing |
US5516532A (en) | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
US5931165A (en) | 1994-09-06 | 1999-08-03 | Fusion Medical Technologies, Inc. | Films having improved characteristics and methods for their preparation and use |
WO1996010374A1 (en) | 1994-10-03 | 1996-04-11 | Otogen Corporation | Differentially biodegradable biomedical implants |
FR2726571B1 (fr) | 1994-11-03 | 1997-08-08 | Izoret Georges | Colle biologique, procede de preparation et dispositif d'application pour colle biologique, et durcisseurs pour colle biologique |
US20030039695A1 (en) | 2001-08-10 | 2003-02-27 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Collagen carrier of therapeutic genetic material, and method |
US5698213A (en) | 1995-03-06 | 1997-12-16 | Ethicon, Inc. | Hydrogels of absorbable polyoxaesters |
US5580923A (en) | 1995-03-14 | 1996-12-03 | Collagen Corporation | Anti-adhesion films and compositions for medical use |
US6287341B1 (en) | 1995-05-19 | 2001-09-11 | Etex Corporation | Orthopedic and dental ceramic implants |
US5677284A (en) | 1995-06-06 | 1997-10-14 | Regen Biologics, Inc. | Charged collagen particle-based delivery matrix |
US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
US5863984A (en) * | 1995-12-01 | 1999-01-26 | Universite Laval, Cite Universitaire | Biostable porous material comprising composite biopolymers |
US5752974A (en) | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
CA2239775C (en) | 1995-12-18 | 2008-07-15 | Collagen Corporation | Crosslinked polymer compositions and methods for their use |
US6458889B1 (en) | 1995-12-18 | 2002-10-01 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
US5748318A (en) | 1996-01-23 | 1998-05-05 | Brown University Research Foundation | Optical stress generator and detector |
US5782917A (en) | 1996-02-26 | 1998-07-21 | Sunmed, Inc. | Intramedullary bone plug |
AU726163B2 (en) | 1996-04-04 | 2000-11-02 | Baxter Healthcare Sa | Hemostatic sponge based on collagen |
CA2251129A1 (en) | 1996-05-03 | 1997-11-13 | Innogenetics N.V. | New medicaments containing gelatin cross-linked with oxidized polysaccharides |
FR2749759B1 (fr) | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
US5902832A (en) | 1996-08-20 | 1999-05-11 | Menlo Care, Inc. | Method of synthesizing swollen hydrogel for sphincter augmentation |
US6063061A (en) | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US7320962B2 (en) | 1996-08-27 | 2008-01-22 | Baxter International Inc. | Hemoactive compositions and methods for their manufacture and use |
US6706690B2 (en) | 1999-06-10 | 2004-03-16 | Baxter Healthcare Corporation | Hemoactive compositions and methods for their manufacture and use |
US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US7435425B2 (en) | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
US7871637B2 (en) | 1996-08-27 | 2011-01-18 | Baxter International Inc. | Dry hemostatic compositions and methods for their preparation |
JP3602145B2 (ja) | 1997-06-03 | 2004-12-15 | イノジェネティックス・ナムローゼ・フェンノートシャップ | メタクリルアミド修飾ゼラチンから構成されるポリマーに基づく新たな医薬品 |
US5908054A (en) | 1997-06-16 | 1999-06-01 | Fusion Medical Technologies, Inc. | Fluid dispersion and delivery assembly and method |
US5997895A (en) | 1997-09-16 | 1999-12-07 | Integra Lifesciences Corporation | Dural/meningeal repair product using collagen matrix |
JP2003510101A (ja) | 1997-09-16 | 2003-03-18 | インテグラ・ライフサイエンスィーズ・コーポレーション | 硬膜又は髄膜組織成長促進用コラーゲン含有製品 |
FR2772746B1 (fr) | 1997-12-23 | 2000-01-28 | Commissariat Energie Atomique | Procede de fabrication d'une ceramique apatitique, en particulier pour usage biologique |
US6179872B1 (en) | 1998-03-17 | 2001-01-30 | Tissue Engineering | Biopolymer matt for use in tissue repair and reconstruction |
US6110484A (en) | 1998-11-24 | 2000-08-29 | Cohesion Technologies, Inc. | Collagen-polymer matrices with differential biodegradability |
US6328229B1 (en) | 1998-12-18 | 2001-12-11 | Cohesion Technologies, Inc. | Low volume mixing spray head for mixing and dispensing of two reactive fluid components |
US20020081732A1 (en) * | 2000-10-18 | 2002-06-27 | Bowlin Gary L. | Electroprocessing in drug delivery and cell encapsulation |
US6312725B1 (en) | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
ES2242631T3 (es) * | 1999-07-21 | 2005-11-16 | Imedex Biomateriaux | Espuma de una proteina adhesiva para usos quirurgicos y/o terapeuticos. |
ATE546481T1 (de) | 1999-08-27 | 2012-03-15 | Angiodevice Internat Gmbh | Biologisch verträgliche polymervorrichtung |
US6221109B1 (en) | 1999-09-15 | 2001-04-24 | Ed. Geistlich Söhne AG fur Chemische Industrie | Method of protecting spinal area |
US6312474B1 (en) | 1999-09-15 | 2001-11-06 | Bio-Vascular, Inc. | Resorbable implant materials |
CN1114728C (zh) | 2000-04-21 | 2003-07-16 | 中国石油化工集团公司 | 止血纤维及其制造方法 |
CN1455659A (zh) | 2000-09-12 | 2003-11-12 | 弗吉尼亚州立大学 | 高压出血的治疗 |
EP1320390A2 (en) | 2000-09-18 | 2003-06-25 | Organogenesis Inc. | Bioengineered flat sheet graft prosthesis and its use |
CA2434964C (en) | 2001-01-25 | 2009-04-21 | Nycomed Pharma As | Carrier with solid fibrinogen and solid thrombin |
US8187625B2 (en) * | 2001-03-12 | 2012-05-29 | Boston Scientific Scimed, Inc. | Cross-linked gelatin composition comprising a wetting agent |
US7262174B2 (en) | 2001-05-09 | 2007-08-28 | Geron Corporation | Treatment for wounds |
DE10225420A1 (de) | 2002-06-07 | 2003-12-24 | Sanatis Gmbh | Strontium-Apatit-Zement-Zubereitungen, die daraus gebildeten Zemente und die Verwendung davon |
US20060258560A1 (en) * | 2002-09-30 | 2006-11-16 | Chunlin Yang | Dry tissue sealant compositions |
CN1756571A (zh) * | 2002-12-30 | 2006-04-05 | 血管技术国际股份公司 | 组织反应性化合物和组合物及其应用 |
PT1484070E (pt) | 2003-06-05 | 2006-05-31 | Baxter Int | Composicoes para reparar e regenerar a dura-mater humana |
US8834864B2 (en) | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
JP4056001B2 (ja) | 2003-07-11 | 2008-03-05 | テセラ・インターコネクト・マテリアルズ,インコーポレイテッド | 配線回路基板の製造方法 |
JP2007516740A (ja) | 2003-11-10 | 2007-06-28 | アンジオテック インターナショナル アーゲー | 医療移植片(implants)および瘢痕化抑制剤 |
CA2536041A1 (en) * | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
KR101148445B1 (ko) * | 2004-04-28 | 2012-07-05 | 안지오디바이스 인터내셔널 게엠베하 | 가교된 생합성물질을 형성하기 위한 조성물 및 시스템, 및 이와 관련된 제조 및 사용 방법 |
US20080091277A1 (en) | 2004-08-13 | 2008-04-17 | Kai Deusch | Surgical prosthesis having biodegradable and nonbiodegradable regions |
WO2006031358A2 (en) | 2004-08-13 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses |
GB2418145A (en) * | 2004-09-17 | 2006-03-22 | Ethicon Inc | Wound treatment system |
US7201918B2 (en) * | 2004-11-16 | 2007-04-10 | Microvention, Inc. | Compositions, systems and methods for treatment of defects in blood vessels |
JP2008540725A (ja) | 2005-05-04 | 2008-11-20 | スープラポリックス ビー.ブイ. | 水素結合ヒドロゲル |
WO2007001926A2 (en) | 2005-06-24 | 2007-01-04 | Hyperbranch Medical Technology, Inc. | Low-swelling hydrogel sealants for wound repair |
US7597882B2 (en) | 2006-04-24 | 2009-10-06 | Incept Llc | Protein crosslinkers, crosslinking methods and applications thereof |
CA2651941C (en) | 2006-05-31 | 2015-02-17 | Baxter International Inc. | Method for directed cell in-growth and controlled tissue regeneration in spinal surgery |
TWI436793B (zh) * | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
AU2008230916B2 (en) | 2007-03-26 | 2013-10-03 | Baxter Healthcare S.A. | Injectable void filler for soft tissue augmentation |
US8932619B2 (en) * | 2007-06-27 | 2015-01-13 | Sofradim Production | Dural repair material |
JP2009054505A (ja) | 2007-08-29 | 2009-03-12 | Sumitomo Wiring Syst Ltd | 防水コネクタ |
MX2010004838A (es) | 2007-10-30 | 2010-05-21 | Baxter Int | Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales. |
CA2716872C (en) * | 2008-02-29 | 2015-02-10 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
US20100100123A1 (en) | 2008-10-17 | 2010-04-22 | Confluent Surgical, Inc. | Hemostatic implant |
JP5559190B2 (ja) | 2008-11-19 | 2014-07-23 | アクタマックス サージカル マテリアルズ リミテッド ライアビリティ カンパニー | 繊維状組織シーラントおよびその使用方法 |
US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
US20100297235A1 (en) * | 2009-05-20 | 2010-11-25 | Cpc Of America, Inc. | Vascular puncture closure systems, devices, and methods using biocompatible synthetic hydrogel compositions |
US20110104280A1 (en) * | 2009-05-20 | 2011-05-05 | Olexander Hnojewyj | Wound treatment systems, devices, and methods using biocompatible synthetic hydrogel compositions |
JP5719355B2 (ja) * | 2009-06-16 | 2015-05-20 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | 止血スポンジ |
KR101811070B1 (ko) | 2009-12-16 | 2017-12-20 | 백스터 인터내셔널 인코포레이티드 | 지혈 스폰지 |
SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
US20120101519A1 (en) * | 2010-10-25 | 2012-04-26 | Boston Scientific Scimed, Inc. | Porous vascular closure plug with starch powder |
-
2011
- 2011-04-06 SA SA111320355A patent/SA111320355B1/ar unknown
- 2011-04-07 RU RU2012147275/15A patent/RU2562569C2/ru not_active IP Right Cessation
- 2011-04-07 WO PCT/EP2011/055418 patent/WO2011124640A1/en active Application Filing
- 2011-04-07 CA CA2795099A patent/CA2795099C/en active Active
- 2011-04-07 UY UY0001033320A patent/UY33320A/es not_active Application Discontinuation
- 2011-04-07 US US13/082,114 patent/US8703170B2/en active Active
- 2011-04-07 KR KR1020127029061A patent/KR101832518B1/ko active IP Right Grant
- 2011-04-07 AU AU2011237901A patent/AU2011237901B2/en active Active
- 2011-04-07 AR ARP110101177A patent/AR087327A1/es unknown
- 2011-04-07 ES ES16178209T patent/ES2971671T3/es active Active
- 2011-04-07 BR BR112012025391-3A patent/BR112012025391B1/pt not_active IP Right Cessation
- 2011-04-07 PT PT117125799T patent/PT2555804E/pt unknown
- 2011-04-07 EP EP11712579.9A patent/EP2555804B1/en active Active
- 2011-04-07 MX MX2012011635A patent/MX2012011635A/es active IP Right Grant
- 2011-04-07 NZ NZ602630A patent/NZ602630A/en not_active IP Right Cessation
- 2011-04-07 DK DK11712579.9T patent/DK2555804T3/en active
- 2011-04-07 ES ES11712579.9T patent/ES2546667T3/es active Active
- 2011-04-07 TW TW100111985A patent/TWI511753B/zh active
- 2011-04-07 JP JP2013503115A patent/JP5856142B2/ja active Active
- 2011-04-07 EP EP15165862.2A patent/EP2939697B1/en active Active
- 2011-04-07 CN CN201180028729.4A patent/CN102939113B/zh active Active
- 2011-04-07 EP EP23209359.1A patent/EP4302788A3/en active Pending
- 2011-04-07 ES ES15165862.2T patent/ES2605902T3/es active Active
- 2011-04-07 PL PL11712579T patent/PL2555804T3/pl unknown
- 2011-04-07 PE PE2012001998A patent/PE20130695A1/es not_active Application Discontinuation
- 2011-04-07 US US13/639,490 patent/US20130028975A1/en not_active Abandoned
- 2011-04-07 EP EP16178209.9A patent/EP3103481B1/en active Active
-
2012
- 2012-09-27 CR CR20120492A patent/CR20120492A/es unknown
- 2012-10-05 ZA ZA2012/07502A patent/ZA201207502B/en unknown
- 2012-10-05 CL CL2012002804A patent/CL2012002804A1/es unknown
- 2012-10-31 CO CO12196255A patent/CO6630171A2/es not_active Application Discontinuation
-
2013
- 2013-06-20 HK HK13107218.6A patent/HK1179904A1/xx unknown
-
2014
- 2014-02-19 US US14/184,543 patent/US9375505B2/en active Active
-
2015
- 2015-08-26 HR HRP20150896TT patent/HRP20150896T1/hr unknown
-
2016
- 2016-06-13 US US15/181,280 patent/US10441674B2/en active Active
-
2019
- 2019-10-02 US US16/590,837 patent/US11478566B2/en active Active
-
2022
- 2022-09-16 US US17/946,673 patent/US20230092332A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012025391A2 (pt) | esponja, uso de uma esponja, método de tratamento de uma lesão, kit, método de fabricação de uma esponja hemostática, e , compósito hemostático | |
BR112012014773A2 (pt) | esponja de compósito hemostática, método para fabricar uma esponja de compósito hemostática, e, uso da referida esponja | |
AR070151A1 (es) | Composicion de revestimiento para metales | |
DE602006012813D1 (de) | Beschichtungen zur verwendung auf medizinprodukten | |
MX356582B (es) | Recubrimiento para dispositivo medico lubrico con bajo nivel de material particulado. | |
BR112012033497A2 (pt) | painel compreendendo uma camada de compósito polimérico e uma camada de reforço | |
DE602005013079D1 (de) | Konstruktionsverfahren unter verwendung eines umkapselten klebstoffs | |
EP2265234A4 (en) | MEDICAL ASSOCIATIONS WITH VALVE AND THESE INCLUDING KITS | |
BR112017016552A2 (pt) | ?compósitos de polímeros sintéticos de alta resistência de camada única para válvulas protéticas? | |
WO2012082611A3 (en) | Porous films by backfilling with reactive compounds | |
BRPI0720153A8 (pt) | Composições e artigos que contêm uma matriz de polímero reticulada e um líquido ativo imobilizado assim como processos de utilização dos mesmos | |
BRPI0911507B8 (pt) | método para provisão de nanocelulose envolvendo modificação de fibras de celulose | |
BR112013000098A2 (pt) | artigos abrasivos revestidos | |
BRPI0907663A8 (pt) | composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições | |
BRPI0918348A2 (pt) | Processo de polimerização e composição | |
DE602007004886D1 (de) | Fluorhaltiges Organopolysiloxan, dieses enthaltende Zusammensetzung zur Oberflächenbehandlung und mit der Zusammensetzung behandelter Gegenstand | |
BRPI0815649A8 (pt) | Revestimento | |
MX2021008462A (es) | Materiales de colageno estratificados y metodos para fabricarlos. | |
BR112013000169A2 (pt) | material compósito feito de um material contendo celulose com pmma como uma matriz de plástico usando diferentes componentes de acoplamento | |
BRPI0818544A2 (pt) | Processo para tratamento de uma combinação contendo organossilano, composição e uso de uma resina orgânica. | |
MY163472A (en) | Polymer compositions | |
MX2011011856A (es) | Peliculas que contienen una mayor concentracion de zinc. | |
BR112018007787A2 (pt) | revestimento de mescla de hidrogel à base de água e método de aplicação a artigos elastoméricos | |
TR201817959T4 (tr) | 2k isi i̇le sertleşen toz kaplama bi̇leşi̇mleri̇. | |
BR112018008388A2 (pt) | composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/04/2011, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/04/2011, OBSERVADAS AS CONDICOES LEGAIS |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2769 DE 30-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |